This paper is only available as a PDF. To read, Please Download here.
ABSTRACT
Purpose
Missense variants clustering in the BTB domain region of RHOBTB2 cause a developmental and epileptic encephalopathy (DEE) with early-onset seizures
and severe intellectual disability.
Methods
By international collaboration we assembled individuals with pathogenic RHOBTB2 variants and a variable spectrum of neurodevelopmental disorders (NDDs). By western
blotting we investigated the consequences of missense variants in vitro.
Results
In accordance with previous observations, de novo heterozygous missense variants in the BTB domain region led to a severe DEE in 16
individuals. We now identified also de novo missense variants in the GTPase domain in six individuals with apparently more variable
neurodevelopmental phenotypes with or without epilepsy. In contrast to variants in
the BTB domain region, variants in the GTPase domain do not impair proteasomal degradation
of RHOBTB2 in vitro, indicating different functional consequences.Furthermore, we observed bi-allelic splice-site and truncating variants in nine families
with variable neurodevelopmental phenotypes, indicating that complete loss of RHOBTB2 is pathogenic as well.
Conclusion
By identifying phenotype-genotype correlations regarding location and consequences
of de novo missense variants in RHOBTB2 and by identifying bi-allelic truncating variants, we further delineate and expand
the molecular and clinical spectrum of RHOBTB2 related disorders including both autosomal dominant and recessive NDDs.
Keywords
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
ACMG Member Login
Are you an ACMG Member? Sign in for online access.Subscribe:
Subscribe to Genetics in MedicineAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
Article info
Publication history
Accepted:
May 3,
2023
Received in revised form:
May 3,
2023
Received:
February 17,
2023
Publication stage
In Press Accepted ManuscriptFootnotes
CONFLICT OF INTEREST
J.B.R. Serves on the editorial board for the journal Neurology and has received consulting fees from Supernus Pharmaceuticals.
All other authors declare no conflicts of interest.
Identification
Copyright
© 2023 American College of Medical Genetics and Genomics. Published by Elsevier Inc. All rights reserved.
